BG105618A - Beta-amido and beta-sulphonamide derivatives of carboxylic acids, method for preparation and application as endothelin-receptor antagonists - Google Patents
Beta-amido and beta-sulphonamide derivatives of carboxylic acids, method for preparation and application as endothelin-receptor antagonistsInfo
- Publication number
- BG105618A BG105618A BG105618A BG10561801A BG105618A BG 105618 A BG105618 A BG 105618A BG 105618 A BG105618 A BG 105618A BG 10561801 A BG10561801 A BG 10561801A BG 105618 A BG105618 A BG 105618A
- Authority
- BG
- Bulgaria
- Prior art keywords
- beta
- endothelin
- preparation
- application
- receptor antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/22—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to two ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19858779A DE19858779A1 (de) | 1998-12-18 | 1998-12-18 | Neue ß-Amido und ß-Sulfonamidocarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
PCT/EP1999/009679 WO2000037450A1 (de) | 1998-12-18 | 1999-12-09 | NEUE β-AMIDO- UND β-SULFONAMIDOCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELIN-REZEPTORANTAGONISTEN |
Publications (1)
Publication Number | Publication Date |
---|---|
BG105618A true BG105618A (en) | 2002-01-31 |
Family
ID=7891778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG105618A BG105618A (en) | 1998-12-18 | 2001-06-18 | Beta-amido and beta-sulphonamide derivatives of carboxylic acids, method for preparation and application as endothelin-receptor antagonists |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1140867A1 (pt) |
JP (1) | JP2002533330A (pt) |
KR (1) | KR20010101279A (pt) |
CN (1) | CN1334806A (pt) |
AR (1) | AR023353A1 (pt) |
AU (1) | AU3036400A (pt) |
BG (1) | BG105618A (pt) |
BR (1) | BR9916331A (pt) |
CA (1) | CA2355251A1 (pt) |
CZ (1) | CZ20012186A3 (pt) |
DE (1) | DE19858779A1 (pt) |
HK (1) | HK1042095A1 (pt) |
HU (1) | HUP0201321A3 (pt) |
IL (1) | IL143451A0 (pt) |
NO (1) | NO20013000L (pt) |
SK (1) | SK8682001A3 (pt) |
TR (1) | TR200101780T2 (pt) |
WO (1) | WO2000037450A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03003482A (es) * | 2000-11-17 | 2004-09-10 | Warner Lambert Co | Tratamiento de disfuncion sexual. |
US7790770B2 (en) | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US8962832B2 (en) * | 2009-07-10 | 2015-02-24 | Cadila Healthcare Limited | Process for the preparation of ambrisentan and novel intermediates thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8912700D0 (en) * | 1989-06-02 | 1989-07-19 | Shell Int Research | Herbicidal compounds |
DE4329911A1 (de) * | 1993-09-04 | 1995-03-09 | Basf Ag | Substituierte Milchsäurederivate mit einem N-organischen Rest in beta-Position |
US6448248B1 (en) * | 1996-12-18 | 2002-09-10 | Abbott Laboratories | Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists |
DE19726146A1 (de) * | 1997-06-19 | 1998-12-24 | Basf Ag | Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
-
1998
- 1998-12-18 DE DE19858779A patent/DE19858779A1/de not_active Withdrawn
-
1999
- 1999-12-09 EP EP99964533A patent/EP1140867A1/de not_active Withdrawn
- 1999-12-09 AU AU30364/00A patent/AU3036400A/en not_active Abandoned
- 1999-12-09 CA CA002355251A patent/CA2355251A1/en not_active Abandoned
- 1999-12-09 SK SK868-2001A patent/SK8682001A3/sk unknown
- 1999-12-09 JP JP2000589522A patent/JP2002533330A/ja active Pending
- 1999-12-09 BR BR9916331-4A patent/BR9916331A/pt not_active Application Discontinuation
- 1999-12-09 CN CN99814580A patent/CN1334806A/zh active Pending
- 1999-12-09 TR TR2001/01780T patent/TR200101780T2/xx unknown
- 1999-12-09 IL IL14345199A patent/IL143451A0/xx unknown
- 1999-12-09 WO PCT/EP1999/009679 patent/WO2000037450A1/de not_active Application Discontinuation
- 1999-12-09 CZ CZ20012186A patent/CZ20012186A3/cs unknown
- 1999-12-09 KR KR1020017007615A patent/KR20010101279A/ko not_active Application Discontinuation
- 1999-12-09 HU HU0201321A patent/HUP0201321A3/hu unknown
- 1999-12-17 AR ARP990106523A patent/AR023353A1/es unknown
-
2001
- 2001-06-15 NO NO20013000A patent/NO20013000L/no not_active Application Discontinuation
- 2001-06-18 BG BG105618A patent/BG105618A/xx unknown
-
2002
- 2002-05-31 HK HK02104116.9A patent/HK1042095A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
NO20013000D0 (no) | 2001-06-15 |
SK8682001A3 (en) | 2002-08-06 |
HUP0201321A3 (en) | 2003-02-28 |
CA2355251A1 (en) | 2000-06-29 |
KR20010101279A (ko) | 2001-11-14 |
CZ20012186A3 (cs) | 2002-07-17 |
AU3036400A (en) | 2000-07-12 |
BR9916331A (pt) | 2001-09-11 |
EP1140867A1 (de) | 2001-10-10 |
AR023353A1 (es) | 2002-09-04 |
DE19858779A1 (de) | 2000-06-21 |
NO20013000L (no) | 2001-08-15 |
CN1334806A (zh) | 2002-02-06 |
HUP0201321A2 (hu) | 2002-12-28 |
JP2002533330A (ja) | 2002-10-08 |
TR200101780T2 (tr) | 2001-11-21 |
IL143451A0 (en) | 2002-04-21 |
HK1042095A1 (zh) | 2002-08-02 |
WO2000037450A1 (de) | 2000-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG103964A (en) | SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS | |
EP0271287A3 (en) | Quinoline dioic acids and amides | |
BG103485A (en) | Ketobanzamides as calpain inhibitors | |
BG106440A (en) | Nitrogen-heterocyclic derivatives as nos inhibitors | |
AU2482800A (en) | Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors | |
BG105177A (en) | Novel substituted pyrazole derivatives | |
BG104831A (en) | Heterocyclically substituted amides, their production and their use | |
AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
BG105009A (en) | Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline | |
BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
UA49884C2 (uk) | ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ | |
CA2333008A1 (en) | New heterocyclically substituted amides, their production and their use | |
MX9801987A (es) | Nuevos derivados de aminoacido, su obtencion y su uso. | |
IL112020A0 (en) | Arylacetic acid derivatives, their preparation and their use as fungicides | |
NZ300942A (en) | 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists | |
PL336640A1 (en) | Substituted 3,3-diamino-2- propenonitriles, their production and application | |
DE69706981D1 (de) | Verfahren zur herstellung von pyrimidin-derivaten | |
MY120550A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions. | |
BG104291A (en) | 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use | |
MD502G2 (ro) | Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin | |
BG102770A (en) | New derivatives of carboxylic acids, their preparation and application | |
ATE386525T1 (de) | 3-substituierte 6,7- dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel | |
BG103502A (en) | Heterocyclic derivatives of carboxylic acids, their preparation and application as endothelial receptor antagonists | |
BG105618A (en) | Beta-amido and beta-sulphonamide derivatives of carboxylic acids, method for preparation and application as endothelin-receptor antagonists | |
BG104022A (en) | New beta-amino and beta-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists |